Download App
ISBN
:
9780309158893
Publisher
:
National Academies Press
Subject
:
Others
Binding
:
PAPERBACK
Pages
:
94
Year
:
2011
₹
2046.0
₹
1861.0
Buy Now
Shipping charges are applicable for books below Rs. 101.0
View Details(Imported Edition) Estimated Shipping Time : 25-28 Business Days
View DetailsDescription
The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it.
Related Items
-
of
Future Opportunities to Leverage the Alzheimer's Disease Neuroimaging Initiative: Workshop Summary
Forum on Neuroscience and Nervous System Disorders
Starts At
1254.0
1364.0
8% OFF
Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary
Forum on Neuroscience and Nervous System Disorders
Starts At
1738.0
1910.0
9% OFF
Health Literacy Implications for Health Care Reform: Workshop Summary
Roundtable on Health Literacy
Starts At
2731.0
3002.0
9% OFF
Implementing a National Cancer Clinical Trials System for the 21st Century: Workshop Summary
National Cancer Policy Forum
Starts At
3228.0
3548.0
9% OFF
Improving Access to Oral Health Care for Vulnerable and Underserved Populations
Committee on Oral Health Access to Services
Starts At
4285.0
4709.0
9% OFF
Learning What Works: Infrastructure Required for Comparative Effectiveness Research: Workshop Summary (The Learning Health System Series)
LeighAnne Olsen
Starts At
6784.0
7455.0
9% OFF
Long-Term Health Consequences of Exposure to Burn Pits in Iraq and Afghanistan
Committee on the Long-Term Health Consequences of Exposure to Burn Pits in Iraq and Afghanistan
Starts At
4571.0
5024.0
9% OFF
Measuring Progress in Obesity Prevention: Workshop Report
Committee on Accelerating Progress in Obesity Prevention
Starts At
3290.0
3616.0
9% OFF
The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop
Development
Starts At
3104.0
3411.0
9% OFF